Highlander Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$769 Hold
610
﹤0.01% 888
2023
Q4
$1.09K Hold
610
﹤0.01% 903
2023
Q3
$1K Buy
+610
New +$1K ﹤0.01% 879